These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 29924909)

  • 1. Use of polyvalent bacteriophages to combat biofilm of Proteus mirabilis causing catheter-associated urinary tract infections.
    Maszewska A; Zygmunt M; Grzejdziak I; Różalski A
    J Appl Microbiol; 2018 Nov; 125(5):1253-1265. PubMed ID: 29924909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phage Cocktail To Control Surface Colonization by Proteus mirabilis in Catheter-Associated Urinary Tract Infections.
    Mirzaei A; Wagemans J; Nasr Esfahani B; Lavigne R; Moghim S
    Microbiol Spectr; 2022 Oct; 10(5):e0209222. PubMed ID: 36194151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of polyvalent bacteriophages specific to uropathogenic Proteus mirabilis strains based on the host range pattern and RFLP.
    Maszewska A; Wójcik E; Ciurzyńska A; Wojtasik A; Piątkowska I; Dastych J; Różalski A
    Acta Biochim Pol; 2016; 63(2):303-10. PubMed ID: 26730411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of multidrug-resistant Proteus mirabilis biofilms using bacteriophages.
    Gomaa S; Serry F; Abdellatif H; Abbas H
    Arch Virol; 2019 Sep; 164(9):2265-2275. PubMed ID: 31197549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and Characterization of a Lytic Bacteriophage (vB_PmiS-TH) and Its Application in Combination with Ampicillin against Planktonic and Biofilm Forms of Proteus mirabilis Isolated from Urinary Tract Infection.
    Yazdi M; Bouzari M; Ghaemi EA
    J Mol Microbiol Biotechnol; 2018; 28(1):37-46. PubMed ID: 29617701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalase Activity is Critical for Proteus mirabilis Biofilm Development, Extracellular Polymeric Substance Composition, and Dissemination during Catheter-Associated Urinary Tract Infection.
    White AN; Learman BS; Brauer AL; Armbruster CE
    Infect Immun; 2021 Sep; 89(10):e0017721. PubMed ID: 34280035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of three lytic bacteriophages for eradicating biofilms of multidrug-resistant Proteus mirabilis.
    Esmael A; Abo-Elmaaty SA; Khafaga EM; Abdelrahman S; Hassan MG
    Arch Virol; 2021 Dec; 166(12):3311-3322. PubMed ID: 34559314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model.
    Lehman SM; Donlan RM
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1127-37. PubMed ID: 25487795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The assessment of Proteus mirabilis susceptibility to ceftazidime and ciprofloxacin and the impact of these antibiotics at subinhibitory concentrations on Proteus mirabilis biofilms.
    Kwiecińska-Piróg J; Skowron K; Zniszczol K; Gospodarek E
    Biomed Res Int; 2013; 2013():930876. PubMed ID: 24151628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Phage Cocktail to Control Proteus mirabilis Catheter-associated Urinary Tract Infections.
    Melo LD; Veiga P; Cerca N; Kropinski AM; Almeida C; Azeredo J; Sillankorva S
    Front Microbiol; 2016; 7():1024. PubMed ID: 27446059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cranberry derivatives enhance biofilm formation and transiently impair swarming motility of the uropathogen Proteus mirabilis HI4320.
    O'May C; Amzallag O; Bechir K; Tufenkji N
    Can J Microbiol; 2016 Jun; 62(6):464-74. PubMed ID: 27090825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophage therapy for inhibition of multi drug-resistant uropathogenic bacteria: a narrative review.
    Chegini Z; Khoshbayan A; Vesal S; Moradabadi A; Hashemi A; Shariati A
    Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):30. PubMed ID: 33902597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophage Can Prevent Encrustation and Blockage of Urinary Catheters by Proteus mirabilis.
    Nzakizwanayo J; Hanin A; Alves DR; McCutcheon B; Dedi C; Salvage J; Knox K; Stewart B; Metcalfe A; Clark J; Gilmore BF; Gahan CG; Jenkins AT; Jones BV
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1530-6. PubMed ID: 26711744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indwelling Urinary Catheter Model of Proteus mirabilis Infection.
    Smith SN; Armbruster CE
    Methods Mol Biol; 2019; 2021():187-200. PubMed ID: 31309506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis and Escherichia coli.
    Carson L; Gorman SP; Gilmore BF
    FEMS Immunol Med Microbiol; 2010 Aug; 59(3):447-55. PubMed ID: 20528927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activities against biofilm formed by Proteus mirabilis isolates from wound and urinary tract infections.
    Wasfi R; Abd El-Rahman OA; Mansour LE; Hanora AS; Hashem AM; Ashour MS
    Indian J Med Microbiol; 2012; 30(1):76-80. PubMed ID: 22361765
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Pawar S; Ashraf MI; Mujawar S; Mishra R; Lahiri C
    Front Cell Infect Microbiol; 2018; 8():269. PubMed ID: 30131943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Biofilm Forming Capability and Antibiotic Resistance in
    Egbule OS; Konye OP; Iweriebor BC
    Pak J Biol Sci; 2024 Apr; 27(5):268-275. PubMed ID: 38840467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Probiotics Bacillus subtilis KATMIRA1933 and Bacillus amyloliquefaciens B-1895 Co-Aggregate with Clinical Isolates of Proteus mirabilis and Prevent Biofilm Formation.
    Algburi A; Alazzawi SA; Al-Ezzy AIA; Weeks R; Chistyakov V; Chikindas ML
    Probiotics Antimicrob Proteins; 2020 Dec; 12(4):1471-1483. PubMed ID: 31989448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence factors in Proteus bacteria from biofilm communities of catheter-associated urinary tract infections.
    Hola V; Peroutkova T; Ruzicka F
    FEMS Immunol Med Microbiol; 2012 Jul; 65(2):343-9. PubMed ID: 22533980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.